We are developing a potential break-through COVID-19 immunisation. Learn More
Meet our executive and scientific

Team

Board & Executive

Executive Team.

Wesley Cooke
Founder and Chief Executive Officer
Marco Stacke
Chief Operations Officer
Immubio Platform

Scientific.

Dr Gustavo Bracho
PhD, BSc.
Chief Immubio Scientist
View Profile
Dr Alexander Tournier
BScCantab PhD LCHE RSHom
Immuno Scientist
View Profile

Explore the science behind our work.

Discover more about our platform and why the work we are doing is critical in providing the global community with a safe, effective and sustainable immunisation program.
Discover the science
Disclaimer

The Immubio platform and ImmubioCV are currently in the early-stage development phase. The Immubio platform and any produced immunisations are being developed for government direct sales and as such we will not sell directly to consumers. Our Immubio range of immunisations are yet to be tested for safety and effectiveness. Studies are planned to confirm safety and effectiveness. Any claims made on this site or in Open Care documents have not been reviewed or evaluated by any international or local health regulators including but not limited to the FDA, HC, EMA or TGA. Until the Immubio platform and ImmubioCV products are registered with the relevant health regulators, all Immubio products that we develop will not be available for use or supply except for use in clinical trials. If you have a serious health concern, please follow official government and medical guidelines and seek professional medical advice.